login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MOLECULAR PARTNERS AG -ADR (MOLN) Stock News
NASDAQ:MOLN -
US60853G1067
-
ADR
3.75
USD
+0.15 (+4.16%)
Last: 8/29/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MOLN Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Benzinga
- Mentions:
EPIX
LPTX
NBTX
FEMY
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
7 days ago - By: Benzinga
- Mentions:
HMY
DQ
ECX
EH
...
EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
7 days ago - By: Molecular Partners
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
7 days ago - By: Molecular Partners
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
12 days ago - By: Molecular Partners
Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics
12 days ago - By: Molecular Partners
Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics
2 months ago - By: Molecular Partners
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
2 months ago - By: Molecular Partners
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
3 months ago - By: Molecular Partners
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
3 months ago - By: Molecular Partners
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
3 months ago - By: Molecular Partners
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
3 months ago - By: Molecular Partners
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
4 months ago - By: Molecular Partners
Molecular Partners to Present at Upcoming Investor Conferences
4 months ago - By: Molecular Partners
Molecular Partners to Present at Upcoming Investor Conferences
4 months ago - By: Molecular Partners
Molecular Partners Reports Financial Results and Highlights from Q1 2025
4 months ago - By: Molecular Partners
Molecular Partners Reports Financial Results and Highlights from Q1 2025
4 months ago - By: Molecular Partners
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
4 months ago - By: Molecular Partners
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
5 months ago - By: Molecular Partners
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
5 months ago - By: Molecular Partners
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
5 months ago - By: Molecular Partners
Molecular Partners to hold three poster presentations at AACR 2025
5 months ago - By: Molecular Partners
Molecular Partners to hold three poster presentations at AACR 2025
5 months ago - By: Molecular Partners
Molecular Partners Publishes Invitation to Annual General Meeting 2025
5 months ago - By: Molecular Partners
Molecular Partners Publishes Invitation to Annual General Meeting 2025
6 months ago - By: Molecular Partners
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024
6 months ago - By: Molecular Partners
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024
6 months ago - By: Molecular Partners
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call
6 months ago - By: Molecular Partners
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call
8 months ago - By: Molecular Partners
Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference
8 months ago - By: Molecular Partners
Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer
Please enable JavaScript to continue using this application.